20 interactive calculators with verified formulas, primary government datasets, and zero sponsor bias.
Excess mortality in mental disorders varies significantly by diagnosis, clinical context, and time since diagnosis.
Excess mortality associated with mental disorders is a well-established issue, but estimates are often based on specialist psychiatric populations. According to editorial research analyzed by Groundwork, Whether these estimates accurately characterize mortality in the broader diagnosed population is uncertain. A recent nationwide population-based cohort study aimed to address this knowledge gap by examining heterogeneity in excess mortality across mental, behavioural, and neurodevelopmental disorders.
The study employed a nationwide population-based cohort design with follow-up from January 1, 2011, through December 31, 2023. The study setting included primary and specialist health care and population registers in Finland. Participants were residents aged 5 to 95 years without a recorded prevalent mental disorder at cohort entry. The study exposures included mental, behavioural, and neurodevelopmental disorders classified using ICD-11, with time-varying psychiatric care setting and substance use disorder (SUD) status.
Among 5,526,599 individuals (2,784,897 [50.4%] women), 1,463,064 (26.5%) received a mental disorder diagnosis. Excess mortality varied substantially by diagnosis, clinical subgroup, and time since diagnosis. Among those aged 5 to 64 years with any mental disorder, adjusted mortality rate ratios (MRRs) across care setting and SUD strata ranged from 1.54 (95% CI, 1.39-1.71) to 8.97 (7.86-10.24). MRRs were highest immediately after first diagnosis and declined during the first 2 to 3 years.
| Diagnosis | MRR (95% CI) | Time Since Diagnosis |
|---|---|---|
| Depressive Disorders | 1.54 (1.39-1.71) | Immediate |
| Anxiety or Fear-Related Disorders | 1.63 (1.45-1.84) | Immediate |
| Stress-Related Disorders | 1.72 (1.53-1.94) | Immediate |
| Schizophrenia and Other Primary Psychotic Disorders | 1.84 (1.60-2.12) | Immediate |
| Depressive Disorders | 0.88 (0.79-0.98) | 3 years |
| Anxiety or Fear-Related Disorders | 0.93 (0.84-1.03) | 3 years |
| Stress-Related Disorders | 1.00 (0.91-1.10) | 3 years |
| Schizophrenia and Other Primary Psychotic Disorders | 1.55 (1.37-1.75) | 3 years |
Ten-year survival loss across all mental disorders was 0.53 years (95% CI, 0.53-0.54) in men and 0.34 years (0.33-0.34) in women. This loss was greater for natural than external causes.
Excess mortality varied markedly by diagnosis, clinical context, and time since diagnosis. Estimates derived from specialist psychiatric populations or averaged across follow-up may therefore provide an incomplete picture of mortality in the broader diagnosed population. This study highlights the importance of considering heterogeneity in excess mortality when developing strategies to address mental health disparities.
“This study provides valuable insights into the complexities of excess mortality in mental disorders. The findings emphasize the need for nuanced approaches to addressing mental health disparities, taking into account the specific characteristics of different diagnoses and clinical contexts.”
Excess mortality in mental disorders refers to the increased risk of death among individuals with mental disorders compared to the general population.
The study found that excess mortality varied substantially by diagnosis, clinical subgroup, and time since diagnosis. MRRs were highest immediately after first diagnosis and declined during the first 2 to 3 years.
The study highlights the importance of considering heterogeneity in excess mortality when developing strategies to address mental health disparities.
The study was limited to a Finnish population and may not be generalizable to other populations.

Early breast cancer detection saved Katherine LaNasa's life. Learn how to prioritize your health and reduce your risk of developing breast cancer.
Early detection of ovarian cancer remains a clinical challenge because available blood biomarkers lack the sensitivity and specificity required for population
Altered EEG patterns co-vary with specific improvements in mind health at summer camp, suggesting that exposure to device-free natural environments supports
Explore related evidence-based investigations, decision tools, and entity breakdowns:
Contextual evidence and verified documentation referenced in this research guide
Groundwork enforces a strict, independent verification standard. All claims and benchmark figures in this guide are cross-referenced against the primary documentation and regulatory registries listed below:
Maya Okafor (2026). Understanding Excess Mortality in Mental Disorders: A Nationwide Study. Groundwork. Retrieved from https://gworky.com/article/excess-mortality-mental-disorders
Originally published at https://gworky.com/article/excess-mortality-mental-disorders — Groundwork Evidence-Based Research.
Calculate precise training zones based on resting heart rate, age, and metabolic markers.
Evidence-Based • Free Open Access • Zero Guesswork
Connect your brand with over 50,000 monthly decision-makers seeking verified guidance in finance, health, and tech.
Calculate personalized cardiovascular training zones based on age and resting metrics.
bodyEarly Breast Cancer Detection Saved Katherine LaNasa's Life: A Cautionary Tale
AI Detects a Distributed Blood Metabolomic Systemotype
Altered EEG Patterns Co-Vary with Specific Improvements in Mind Health at Summer Camp
Epigenetic Signatures of Biological Vulnerability and Residual Risk in Heart Failure
Evaluated for performance, privacy protocols, and pricing transparency.
| Solution | Key Benchmark | Pricing | Verdict & Access |
|---|---|---|---|
Check My Body HealthEditor Pick via Check My Body Health | Clinical food sensitivity & biomarker panels | $38 Test Kit | |
AG1 Protocol via Athletic Greens | NSF Certified daily micronutrient complex | $79/mo | |
Clinical Fasting Guide via Metabolic Research Lab | PubMed-backed metabolic autophagy protocol | $37 One-Time |
Health & Tech Writer
Maya Okafor is a Senior Clinical Sciences Analyst focusing on evidence-based dietary interventions, metabolic longevity markers, and pharmaceutical compounding compliance. Her research bridges molecular biology and applied lifestyle medicine, auditing commercial dietary supplements and evaluating peer-reviewed evidence to help readers distinguish scientifically validated regimens from marketing wellness hype.
Health Data Analyst
Sarah Lin heads clinical analysis for the Body & Health Sciences Desk at Groundwork. She directs primary meta-analyses of peer-reviewed randomized controlled trials (RCTs) indexed in PubMed, evaluating metabolic health, cardiovascular biomarkers, and preventative nutrition protocols. Lin ensures Groundwork's health calculators and wellness guides strictly conform to clinical evidence standards and public health guidelines.
This guide underwent secondary data verification to confirm primary source integrity, calculation formulas, and regulatory compliance before publication.